• OUTLOOK ARENA
  • VIEWS ON NEWS
  • MAY 19, 2000

Pharma, FMCG funds look attractive..and safer

All this bashing of technology, media, telecom (TMT) stocks has made investors realise one very important point - portfolios driven by TMT can go down just as fast as they can go up. Against this backdrop, pharma and FMCG funds look a whole lot safer.

Open-ended Pharma Schemes NAV
(Rs)
Last
week
Last
month
Last
year
Since
inception
Kothari Pioneer Pharma (Gr) 9.6 -2.5% -7.0% 2.5% 2.3%
Magnum Sector Funds - Pharma 8.9 -2.6% -13.5% 0.0% -11.5%
UTI Sector Fund - Pharma 9.5 -4.9% -15.1% 0.0% -20.3%

So is this a case for entry into pharma and FMCG funds? Yes, considering the growth potential of these sectors and the huge correction in TMT stocks, which is showing no signs of abating.

Open-ended FMCG Schemes NAV
(Rs)
Last
week
Last
month
Last
year
Since
inception
Kothari Pioneer FMCG (Gr) 11.0 -3.5% -11.2% 5.8% 11.5%
Pru ICICI FMCG Fund (Gr) 9.1 -1.9% -11.1% 0.0% -11.1%
Magnum Sector Funds - FMCG 8.5 -2.9% -13.1% 0.0% -18.1%

While pharma and FMCG funds haven't shown any growth to write home about, yet the decline in their net asset values (NAVs) is much lower as compared to that of technology funds. As a matter of fact, NAVs of pharma and FMCG funds are very low and look attractive for investors who want to enter low.

Open-ended Software Schemes NAV
(Rs)
Last
week
Last
month
Last
year
Since
inception
Kothari Pioneer Internet Opport. (Gr) 8.2 -6.4% -9.3% 0.0% -14.9%
Sun F & C Emerging Tech. (Gr) 7.1 -9.1% -13.4% 0.0% -17.4%
K Tech 7.7 -9.6% 0.0% 0.0% -2.0%
Kothari Pioneer Infotech (Gr) 29.7 -10.0% -20.8% 212.7% 190.0%
Birla IT Fund (Growth) 21.7 -10.5% -16.0% 95.4% 17.5%
Chola Freedom Technology (Cum) 15.8 -11.6% -18.9% 21.6% 20.9%
Tata IT Sector Fund 12.0 -12.4% -22.4% 99.2% 26.3%
Pru ICICI Tech. Fund (Gr) 5.9 -13.4% -25.5% 0.0% -40.1%
UTI Sector Fund - Software 22.2 -14.4% -27.3% 0.0% 70.4%
IL&FS eCOM Fund (Gr) 6.3 -14.6% -30.9% 0.0% -53.7%
Magnum Sector Funds - IT 15.6 -16.9% -31.2% 0.0% 118.3%
Alliance New Millennium Fund (Gr) 8.1 -17.3% -26.4% 0.0% -47.0%

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst)
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407